Over a decade treating hepatocellular carcinoma percutaneously with radiofrequency thermal ablation. Worldwide experience

Hepatocellular carcinoma (HCC) is a very common malignancy. Early diagnosis plays a significant role in the management of patients, affecting survival and prognosis. Surgical resection is the treatment of choice; yet only a small number of patients are surgical candidates at the time of diagnosis. F...

Full description

Saved in:
Bibliographic Details
Published in:Archives of medical science 2007-12, Vol.3 (4), p.293
Main Authors: Thanos, Loukas, Mylona, Sofia, Ptohis, Nikolaos, Sotiropoulou, Eva, Pomoni, Anastasia, Pomoni, Maria
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hepatocellular carcinoma (HCC) is a very common malignancy. Early diagnosis plays a significant role in the management of patients, affecting survival and prognosis. Surgical resection is the treatment of choice; yet only a small number of patients are surgical candidates at the time of diagnosis. Furthermore, recurrences are very common even after a successful resection. These reasons urged the need to introduce a minimally invasive technique that can be repeated, without the fear of increasing mortality, morbidity, hospitalization and treatment-related cost. In the present article we present our long-standing experience regarding radiofrequency thermal ablation (RFA) treatment of HCC. Indications, clinical results from other investigators and complications are discussed. Additionally there is a description of the technique and the equipment used.
ISSN:1734-1922
1896-9151